Company facts
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Sep 30, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1159036
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 60
News 8 of 183
Prospectuses and Registrations 8 of 17
- S-8 Registration statement for an employee plan Nov 18, 2025
- S-8 Registration statement for an employee plan May 5, 2021
- S-8 Registration statement for an employee plan May 5, 2021
- S-8 POS Post-effective amendment to an employee plan registration May 14, 2019
- S-8 POS Post-effective amendment to an employee plan registration May 14, 2019
- S-8 Registration statement for an employee plan May 10, 2018
- 424B5 Prospectus supplement for an offering May 19, 2017
- 424B5 Prospectus supplement for an offering May 18, 2017
Proxies 8 of 34
- DEFA14A Extra proxy material Mar 23, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 23, 2026
- DEFA14A Extra proxy material Mar 18, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 18, 2025
- DEFA14A Extra proxy material Mar 15, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 15, 2024
- PRE 14A Preliminary proxy statement Mar 4, 2024
- DEFA14A Extra proxy material Mar 24, 2023
Ownership 8 of 674
- 4 Insider reported a trade Oct 8, 2026
- 4/A Insider reported a trade, amended Oct 8, 2026
- 4 Insider reported a trade Oct 2, 2026
- 3 Insider reported their initial holding Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144 Notice of a proposed sale of restricted stock Sep 16, 2026
- 4 Insider reported a trade Sep 11, 2026
Other 8 of 33
- ARS Annual report sent to shareholders Mar 23, 2026
- ARS Annual report sent to shareholders Mar 18, 2025
- ARS Annual report sent to shareholders Mar 15, 2024
- UPLOAD Comment letter from SEC staff Jul 21, 2023
- CORRESP Reply to SEC staff Jun 28, 2023
- UPLOAD Comment letter from SEC staff Jun 14, 2023
- ARS Annual report sent to shareholders Mar 24, 2023
- SC TO-T/A Amended filing May 24, 2022
Everything here comes from Halozyme Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.